Physician profile
Jonathan Dunn
NPI 1942566526
$7,184.21
in general payments reported to CMS, 2019-2025
35 companies · $635 in 2025
The $635 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $782 · 2020: $674 · 2021: $656 · 2022: $1,477 · 2023: $1,738 · 2024: $1,223 · 2025: $635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,595.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $707.14 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $640.09 | 2019-2023 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $535.34 | 2020-2025 | Camzyos, Eliquis |
| Pfizer INC. | $526.92 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $498.87 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $472.98 | 2019-2023 | Watchman Flx |
| Amarin Pharma, INC. | $463.50 | 2020-2023 | |
| Astrazeneca Pharmaceuticals Lp | $361.66 | 2020-2025 | Wainua, Farxiga |
| Novo Nordisk INC | $343.76 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Medtronic, INC. | $264.81 | 2023-2024 | Micra, Claria Mri Quad Crt-D Surescan, Azure Xt Dr Mri Surescan |
| Novartis Pharmaceuticals Corporation | $261.82 | 2020-2025 | |
| Abbott Laboratories | $243.38 | 2020-2022 | |
| Heartflow, INC. | $214.15 | 2023-2024 | Ffrct |
| Shockwave Medical, INC | $163.26 | 2022 | |
| Medtronic Vascular, INC. | $157.46 | 2019 |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Dunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.